Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Time to Progression”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Not applicableActive Not RecruitingNCT06480617
What this trial is testing

Observational, Bivariate Analysis of Clinical Big Data in Patients With Cervical Cancer

Who this might be right for
Progression-free Survival Was Defined From Date of Surgery to Disease Progression Post-surgery or Death or Last Follow-upOverall Survival Was Defined as Time From Surgery to Death From Any Cause or Last Follow-up
Anhui Provincial Hospital 3,000
Testing effectiveness (Phase 2)Study completedNCT00747097
What this trial is testing

Gemcitabine and Cetuximab in Patients With Advanced or Metastatic Biliary Tract Cancer: A Multicenter Phase II Study

Who this might be right for
Time to Progression
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT06449209
What this trial is testing

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

Who this might be right for
Extensive-stage Small-cell Lung CancerSmall-cell Lung Cancer
BioNTech SE 110
Testing effectiveness (Phase 2)Ended earlyNCT02013765
What this trial is testing

Herceptin (Trastuzumab) Monotherapy in Patients With Metastatic Urothelial Cancer

Who this might be right for
Urinary Tract Cancer
Hoffmann-La Roche 5
Not applicableWithdrawnNCT02137811
What this trial is testing

Demographics, Clinical Outcomes, and Physician Attitudes in Patients Who Have Received The MiCK Assay (CorrectChemo)

Who this might be right for
Cancer
Pierian Biosciences
Post-approval studies (Phase 4)Study completedNCT00363311
What this trial is testing

Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men

Who this might be right for
Neoplasms, Prostate
GlaxoSmithKline 302
Not applicableStudy completedNCT01071707
What this trial is testing

Correlating Outcomes With Biochemical Markers to Estimate Time-progression in Idiopathic Pulmonary Fibrosis (IPF)

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Michigan 108
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07159191
What this trial is testing

Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

Who this might be right for
Advanced Renal Cell Carcinoma (aRCC)
Peking Union Medical College Hospital 30
Not applicableEnded earlyNCT02491775
What this trial is testing

Afatinib Genomic Landscape

Who this might be right for
Carcinoma, Non-Small-Cell LungNon-Small Cell Lung CancerNon-small Lung Cancer
Washington University School of Medicine 6
Not applicableStudy completedNCT04768894
What this trial is testing

Impact of Time to Re-staging Transurethral Resection on Recurrence and Progression Rates

Who this might be right for
Bladder Cancer
Saglik Bilimleri Universitesi 109
Testing effectiveness (Phase 2)Study completedNCT01392183
What this trial is testing

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Kidney Cancer
M.D. Anderson Cancer Center 69
Not applicableEnded earlyNCT02431169
What this trial is testing

Genomic Landscape of EGFR Mutant NSCLC Prior to Erlotinib and at the Time of Disease Progression

Who this might be right for
Carcinoma, Non-Small-Cell-LungNon-Small Cell Lung CancerNonsmall Cell Lung Cancer
Washington University School of Medicine 5
Not applicableLooking for participantsNCT04055220
What this trial is testing

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Who this might be right for
Bone SarcomaOsteosarcomaEwing Sarcoma+4 more
Centre Leon Berard 168
Testing effectiveness (Phase 2)UnknownNCT00892827
What this trial is testing

Combined Treatment With Fresh Frozen Plasma and Rituximab (Mabthera) in Patients With Advanced Refractory Chronic Lymphocytic Leukemia

Who this might be right for
Advanced Refractory Chronic Lymphocytic Leukemia
Wolfson Medical Center 10
Testing effectiveness (Phase 2)UnknownNCT01192243
What this trial is testing

Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer Patients

Who this might be right for
ToxicityNon-small Cell Lung Cancer
Fudan University 68
Not applicableLooking for participantsNCT04805255
What this trial is testing

A Neurocognitive Study in Patients With Brain Oligometastases Receiving Hypofractionated SRT

Who this might be right for
Brain Metastases, Adult
Chang Gung Memorial Hospital 135
Testing effectiveness (Phase 2)Study completedNCT02006667
What this trial is testing

Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer

Who this might be right for
Urinary Tract Cancer
Hoffmann-La Roche 13
Testing effectiveness (Phase 2)Looking for participantsNCT07111520
What this trial is testing

A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
BioNTech SE 420
Testing effectiveness (Phase 2)Ended earlyNCT00474188
What this trial is testing

Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Celgene Corporation 26
Testing effectiveness (Phase 2)Study completedNCT00076102
What this trial is testing

Pirfenidone in Children and Young Adults With Neurofibromatosis Type I and Progressive Plexiform Neurofibromas

Who this might be right for
Neurofibromatosis 1Neurofibroma, Plexiform
National Cancer Institute (NCI) 36
Load More Results